propofol has been researched along with Diathesis in 18 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propofol infusion syndrome is a rare condition that mainly affects critically ill patients who receive high doses of this hypnotic for a long time." | 7.96 | Propofol infusion syndrome; are high doses always required? ( Boliart de San Félix, Y; Fernández Morales, M; Sánchez Royo, E; Subirà González, A; Vila Lolo, C, 2020) |
| "Propofol infusion syndrome is a rare condition that mainly affects critically ill patients who receive high doses of this hypnotic for a long time." | 3.96 | Propofol infusion syndrome; are high doses always required? ( Boliart de San Félix, Y; Fernández Morales, M; Sánchez Royo, E; Subirà González, A; Vila Lolo, C, 2020) |
| " The appearance of muscle spasms as a result of the use of propofol, forced us into a second anaesthesia to perform total intravenous anaesthesia with Midazolam." | 3.85 | General anesthesia in patients with syndrome of Poland. ( Díaz-Crespo, J; García-Herrera, F; Vázquez-Mambrilla, Y, 2017) |
| " In vitro, human MHS muscle samples were exposed to propofol and changes in (a) baseline tension and (b) contracture tension on exposure to halothane and caffeine were measured." | 3.68 | Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients. ( Couchman, KG; McKenzie, AJ; Pollock, N, 1992) |
| "Propofol in KH was perfused at 12 microg/ml for the first 15 min of reperfusion and subsequently reduced to 5 microg/ml in propofol treatment groups." | 1.32 | Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity. ( Ansley, DM; Godin, DV; Xia, Z, 2003) |
| "Anaesthetic techniques for malignant hyperthermia susceptible (MHS) patients should include drugs which do not trigger MH and provide stress free conditions." | 1.28 | Effect of propofol on the malignant hyperthermia susceptible pig model. ( Adnet, P; Becq, MC; Krivosic-Horber, R; Reyfort, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Subirà González, A | 1 |
| Fernández Morales, M | 1 |
| Sánchez Royo, E | 1 |
| Boliart de San Félix, Y | 1 |
| Vila Lolo, C | 1 |
| Zhang, JP | 1 |
| Zhang, WJ | 1 |
| Yang, M | 1 |
| Fang, H | 1 |
| Visvabharathy, L | 2 |
| Freitag, NE | 2 |
| Xayarath, B | 1 |
| Weinberg, G | 1 |
| Shilling, RA | 1 |
| Díaz-Crespo, J | 1 |
| Vázquez-Mambrilla, Y | 1 |
| García-Herrera, F | 1 |
| Kumar, N | 1 |
| Hu, WT | 1 |
| Dueñas, N | 1 |
| Zaballos, M | 1 |
| Xia, Z | 1 |
| Godin, DV | 1 |
| Ansley, DM | 1 |
| Sarti, A | 1 |
| Busoni, P | 1 |
| Dell'Oste, C | 1 |
| Bussolin, L | 1 |
| Hudcova, J | 1 |
| Schumann, R | 1 |
| Pollock, AN | 1 |
| McKenzie, AJ | 2 |
| Hodges, M | 1 |
| Snoeck, MM | 1 |
| Plötz, FB | 1 |
| Waalkens, HJ | 1 |
| Verkade, HJ | 1 |
| Hawkes, CA | 1 |
| Couchman, KG | 1 |
| Pollock, N | 1 |
| Crosby, E | 1 |
| Harrison, GG | 1 |
| Cartwright, DP | 1 |
| Krivosic-Horber, R | 1 |
| Reyfort, H | 1 |
| Becq, MC | 1 |
| Adnet, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Changes of Hemodynamics and Vital Organ Function in Intracerebral Hemorrhage During Different General Anesthesia[NCT03129009] | 90 participants (Anticipated) | Interventional | 2017-04-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for propofol and Diathesis
| Article | Year |
|---|---|
Incidence of vomiting in susceptible children under regional analgesia with two different anaesthetic techniques.
Topics: Anesthesia, Conduction; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Intravenous | 2004 |
17 other studies available for propofol and Diathesis
| Article | Year |
|---|---|
Propofol infusion syndrome; are high doses always required?
Topics: Adult; Anesthetics, Inhalation; Anesthetics, Intravenous; Anesthetics, Local; Bupivacaine; Chemical | 2020 |
Propofol attenuates lung ischemia/reperfusion injury though the involvement of the MALAT1/microRNA-144/GSK3β axis.
Topics: Anesthetics, Intravenous; Animals; Autophagy; Biomarkers; Cytokines; Disease Models, Animal; Disease | 2021 |
Propofol Sedation Exacerbates Kidney Pathology and Dissemination of Bacteria during Staphylococcus aureus Bloodstream Infections.
Topics: Animals; Bacteremia; Bacterial Load; Dendritic Cells; Disease Models, Animal; Disease Susceptibility | 2017 |
Propofol Increases Host Susceptibility to Microbial Infection by Reducing Subpopulations of Mature Immune Effector Cells at Sites of Infection.
Topics: Animals; Animals, Outbred Strains; Bacterial Infections; Cell Count; Cells, Cultured; Cross Infectio | 2015 |
General anesthesia in patients with syndrome of Poland.
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intravenous; Breast; Breast Im | 2017 |
Extrapyramidal reaction to ondansetron and propofol.
Topics: Adult; Anesthesia Recovery Period; Anesthetics, Intravenous; Antiemetics; Basal Ganglia Diseases; Di | 2009 |
[Anesthesia for parathyroidectomy in an elderly patient with dermatomyositis and high risk of bronchial aspiration].
Topics: Aged, 80 and over; Androstanols; Anesthesia, Intravenous; Anesthetics, Intravenous; Carcinoma, Squam | 2009 |
Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity.
Topics: Aging; Animals; Antioxidants; Disease Susceptibility; Male; Myocardial Ischemia; Myocardial Reperfus | 2003 |
Undiagnosed catecholamine-secreting paraganglioma and coexisting carcinoid in a patient with MH susceptibility: an unusual anesthetic challenge.
Topics: Adrenergic alpha-Agonists; Adult; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Intravenou | 2007 |
Propofol and malignant hyperthermia susceptibility.
Topics: Acidosis; Adolescent; Adult; Aged; Anesthetics, Intravenous; Arrhythmias, Cardiac; Cause of Death; C | 1997 |
Fatal outcome after propofol sedation in children.
Topics: Anesthetics, Intravenous; Cause of Death; Child; Dantrolene; Disease Susceptibility; Humans; Hypnoti | 1997 |
Factitious halothane detection during trigger-free anesthesia in a malignant hyperthermia susceptible patient.
Topics: Adult; Anesthetics, Intravenous; Anesthetics, Local; Arthrodesis; Arthroscopy; Disease Susceptibilit | 1999 |
Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
Topics: Adolescent; Adult; Anesthesia, Intravenous; Caffeine; Contracture; Disease Susceptibility; Halothane | 1992 |
Does propofol-nitrous oxide anaesthesia provide autonomic hyperreflexia (AH) prophylaxis in susceptible patients?
Topics: Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Autonomic Nervous System; Blood Pressure; Di | 1992 |
Propofol in malignant hyperthermia.
Topics: Anesthesia; Biopsy; Disease Susceptibility; Humans; In Vitro Techniques; Malignant Hyperthermia; Mus | 1991 |
Propofol in patients susceptible to malignant hyperpyrexia.
Topics: Anesthetics; Disease Susceptibility; Female; Humans; Malignant Hyperthermia; Middle Aged; Phenols; P | 1989 |
Effect of propofol on the malignant hyperthermia susceptible pig model.
Topics: Anesthetics; Animals; Disease Models, Animal; Disease Susceptibility; Malignant Hyperthermia; Phenol | 1989 |